But first… what’s Flagship Project 7?
Flagship Project 7 (FP7) is one of eight projects under the #RomeTechnopole initiative: a set of initiatives that bring vertical innovation within strategic specialization areas such as Energy Transition, Digital Transition, and #Health & #BioPharma.
FP7 is led by Takis and Catalent, working closely with CNR, Istituto Superiore di Sanità, Istituto Nazionale di Fisica Nucleare, and the Universities of Sapienza, Tor Vergata, Roma Tre, Tuscia, Cassino, and Campus Bio-Medico.
The Rome Technopole FP7 workshop, that took place yesterday at Università degli Studi Roma Tre, showcased a variety of cutting-edge #research activities highlighting the latest advancements and breakthroughs in these fields.
Our team, led by our CTO Giuseppe Roscilli, shared our latest findings on the topic of Monoclonal antibody development and characterization.
One of Rome Technopole values is the collaboration between public and private sector. We are happy to contribute every time with our work!
In the first photo you can see our team at the workshop, from left to right: Eugenia Principato, Antonella Costanzo, Giovanni Bulfaro, Fabiana Fosca Ferrara, Giuseppe Roscilli, Valerio Chiarini, Ph.D. and Valentina Peluzzi.
